Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Leads The Day Higher, Merck (MRK) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 30 points (+0.2%) at 17,161 as of Wednesday, Sep 17, 2014, 9:36 a.m. ET. During this time, 21 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 293.3 million. The NYSE advances/declines ratio sits at 1,817 issues advancing vs. 867 declining with 277 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be E I du Pont de Nemours & Company (NYSE: DD), which is sporting a $2.80 gain (+4.3%) bringing the stock to $68.63. This single gain is lifting the Dow Jones Industrial Average by 21.19 points or roughly accounting for 70.6% of the Dow's overall gain. Volume for E I du Pont de Nemours & Company currently sits at 2.6 million shares traded vs. an average daily trading volume of 3.7 million shares.

E I du Pont de Nemours & Company has a market cap of $59.77 billion and is part of the basic materials sector and chemicals industry. Shares are up 1.3% year-to-date as of Tuesday's close. The stock's dividend yield sits at 2.9%.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, and rice seed products under the Pioneer brand; and herbicides, fungicides, and insecticides.

TheStreet Ratings rates E I du Pont de Nemours & Company as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Holding back the Dow today is Merck (NYSE: MRK), which is lagging the broader Dow index with a 55-cent decline (-0.9%) bringing the stock to $59.44. Volume for Merck currently sits at 658,016 shares traded vs. an average daily trading volume of 8.1 million shares.

Merck has a market cap of $171.69 billion and is part of the health care sector and drugs industry. Shares are up 19.9% year-to-date as of Tuesday's close. The stock's dividend yield sits at 3%.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.

TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio

Facebook Sends Facial Recognition Notification in Error

Facebook Sends Facial Recognition Notification in Error